Alpha 2.0
Login Register
» Articles » PMID: 29276599

Rapid Resolution of Left Ventricular Thrombus with Apixaban Therapy

Overview
Journal SAGE Open Med Case Rep
Publisher Sage Publications
Specialty General Medicine
Date 2017 Dec 26
PMID 29276599
Citations 5
Authors
Abeer Berry
Daniel Brancheau
Marcel Zughaib
Affiliations
Soon will be listed here.
Abstract

It is a common medical practice to anticoagulate an asymptomatic left ventricular mural thrombus following an ST-elevation myocardial infarction using a vitamin K antagonist. Novel oral anticoagulants have not been studied extensively in this context, and therefore, no recommendations have been made for their use. A 67-year-old male physician with no significant medical history presented to the cardiology clinic complaining of shortness of breath that had been gradually worsening over a 2-week period and was found to have an anterior wall myocardial infarction with apical left ventricular thrombus that was treated with apixaban. We present a case of rapid resolution of left ventricular thrombus with the use of apixaban for anticoagulation. Although there are no guideline recommendations for this use, there have been case series and case reports that have shown safety and efficacy. Apixaban can be used for rapid resolution of left ventricular thrombus treatment.

Citing Articles

Oral Anticoagulant Use and Appropriateness in Elderly Patients with Atrial Fibrillation in Complex Clinical Conditions: ACONVENIENCE Study.

Bonanad C, Formiga F, Anguita M, Petidier R, Gullon A J Clin Med. 2022; 11(24).

PMID: 36556039 PMC: 9781896. DOI: 10.3390/jcm11247423.

The concoction of cancer, catheter, and intracardiac clot: a case report describing a potential treatment strategy.

Nair R, Maroo A Eur Heart J Case Rep. 2020; 4(5):1-6.

PMID: 33204995 PMC: 7649519. DOI: 10.1093/ehjcr/ytaa360.

The role of rivaroxaban in left ventricular thrombi.

Abdelnaby M, Almaghraby A, Abdelkarim O, Saleh Y, Hammad B, Badran H Anatol J Cardiol. 2018; 21(1):47-50.

PMID: 30587707 PMC: 6382905. DOI: 10.14744/AnatolJCardiol.2018.48313.

Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis.

Ghaffarpasand E, Tehrani M, Marszalek J, Chi G J Thromb Thrombolysis. 2018; 46(3):332-338.

PMID: 29876713 DOI: 10.1007/s11239-018-1693-3.

Dabigatran Added to Dual Antiplatelet Therapy to Treat a Left Ventricular Thrombus in an 87 Year Old Patient With Myocardial Infarction and Very High Bleeding Risk.

Noflatscher M, Moes N, Gassner E, Marschang P Front Pharmacol. 2018; 9:217.

PMID: 29670522 PMC: 5893831. DOI: 10.3389/fphar.2018.00217.

References
1.
Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J . European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2013; 15(5):625-51. DOI: 10.1093/europace/eut083. View
2.
Kaya A, Hayiroglu M, Keskin M, Tekkesin A, Alper A . Resolution of left ventricular thrombus with apixaban in a patient with hypertrophic cardiomyopathy. Turk Kardiyol Dern Ars. 2016; 44(4):335-7. DOI: 10.5543/tkda.2015.68054. View
3.
Padilla Perez M, Salas Bravo D, Garcelan Trigo J, Vazquez Ruiz de Castroviejo E, Torres Llergo J, Lozano Cabezas C . Resolution of left ventricular thrombus by rivaroxaban. Future Cardiol. 2014; 10(3):333-6. DOI: 10.2217/fca.14.12. View
4.
Kolekar S, Munjewar C, Sharma S . Dabigatran for left ventricular thrombus. Indian Heart J. 2015; 67(5):495-6. PMC: 4593802. DOI: 10.1016/j.ihj.2015.06.010. View
5.
Khoury S, Carmon S, Margolis G, Keren G, Shacham Y . Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Res Cardiol. 2017; 106(9):695-701. DOI: 10.1007/s00392-017-1111-4. View